CDDO-compounds and combination therapies thereof
US7795305B2 · kind B2 · utility
56Cited by
22References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 10, 2008 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Oct 10, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
CDDO-compounds in combination with other chemotherapeutic agents induce and potentiate cytotoxicity and apoptosis in cancer cell. One class of chemotherapeutic agents include retinoids. Cancer therapies based on these combination therapies are provided. Also provided are methods to treat graft versus host diseases using the CDDO compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.